Pozen (POZN +21.2%) shares spike after the FDA approves its new Vimovo arthritis medication...

|By:, SA News Editor

Pozen (POZN +21.2%) shares spike after the FDA approves its new Vimovo arthritis medication co-developed with AstraZeneca (AZN +0.3%).